159 related articles for article (PubMed ID: 27704355)
1. Serum Heat Shock Protein 70, as a Potential Biomarker for Small Cell Lung Cancer.
Balázs M; Zsolt H; László G; Gabriella G; Lilla T; Gyula O; Balázs D; Éva M; Zoltán B; Zoltán P; Judit K
Pathol Oncol Res; 2017 Apr; 23(2):377-383. PubMed ID: 27704355
[TBL] [Abstract][Full Text] [Related]
2. High serum Hsp70 level predicts poor survival in colorectal cancer: Results obtained in an independent validation cohort.
Gráf L; Barabás L; Madaras B; Garam N; Maláti É; Horváth L; Prohászka Z; Horváth Z; Kocsis J
Cancer Biomark; 2018; 23(4):539-547. PubMed ID: 30452400
[TBL] [Abstract][Full Text] [Related]
3. Circulating Heat Shock Protein 70 Is a Novel Biomarker for Early Diagnosis of Lung Cancer.
Tang T; Yang C; Brown HE; Huang J
Dis Markers; 2018; 2018():6184162. PubMed ID: 30245753
[TBL] [Abstract][Full Text] [Related]
4. Discrimination of clinical stages in non-small cell lung cancer patients by serum HSP27 and HSP70: a multi-institutional case-control study.
Zimmermann M; Nickl S; Lambers C; Hacker S; Mitterbauer A; Hoetzenecker K; Rozsas A; Ostoros G; Laszlo V; Hofbauer H; Renyi-Vamos F; Klepetko W; Dome B; Ankersmit HJ
Clin Chim Acta; 2012 Jul; 413(13-14):1115-20. PubMed ID: 22465083
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and predictive value of plasma D-dimer levels in patients with small-cell lung cancer.
Zhang C; Jia Y; Jia Y; Zhang X; Li K
Int J Clin Oncol; 2018 Dec; 23(6):1070-1075. PubMed ID: 30168089
[TBL] [Abstract][Full Text] [Related]
6. High pretreatment serum C-reactive protein level predicts a poor prognosis for combined small-cell lung cancer.
Shao N; Cai Q
Tumour Biol; 2015 Nov; 36(11):8465-70. PubMed ID: 26026588
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum levels of heat shock protein 70 are associated with breast cancer.
Gunaldi M; Afsar CU; Okuturlar Y; Gedikbasi A; Kocoglu H; Kural A; Akarsu C; Gunduz U; Tiken EE
Tohoku J Exp Med; 2015 Jun; 236(2):97-102. PubMed ID: 26018606
[TBL] [Abstract][Full Text] [Related]
8. Serum pleiotrophin as a diagnostic and prognostic marker for small cell lung cancer.
Xu C; Wang Y; Yuan Q; Wang W; Chi C; Zhang Q; Zhang X
J Cell Mol Med; 2019 Mar; 23(3):2077-2082. PubMed ID: 30635982
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of serum tumor markers, including progastrin-releasing peptide, in patients with lung cancer: correlation with histology.
Molina R; Augé JM; Bosch X; Escudero JM; Viñolas N; Marrades R; Ramírez J; Carcereny E; Filella X
Tumour Biol; 2009; 30(3):121-9. PubMed ID: 19506400
[TBL] [Abstract][Full Text] [Related]
10. Heat shock protein 70 is a useful marker for predicting colorectal cancer.
Gunaldi M; Kocoglu H; Okuturlar Y; Gedikbasi A; Karabulut M; Alis H; Hursitoglu M
J BUON; 2015; 20(6):1464-70. PubMed ID: 26854442
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.
Kim HC; Song JS; Lee JC; Lee DH; Kim SW; Lee JS; Kim WS; Rho JK; Kim SY; Choi CM
Int J Clin Exp Pathol; 2014; 7(10):6743-51. PubMed ID: 25400754
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of potential usefulness of serum lactate dehydrogenase level in follow-up of small cell lung cancer.
Chen C; Zhu YH; Huang JA
J Cancer Res Ther; 2018 Jun; 14(Supplement):S336-S340. PubMed ID: 29970686
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of serum IL-17 and VEGF levels in small cell lung cancer.
Lin Q; Xue L; Tian T; Zhang B; Guo L; Lin G; Chen Z; Fan K; Gu X
Int J Biol Markers; 2015 Nov; 30(4):e359-63. PubMed ID: 26165685
[TBL] [Abstract][Full Text] [Related]
14. The prognostic role of circulating CD8
An N; Wang H; Jia W; Jing W; Liu C; Zhu H; Yu J
J Transl Med; 2019 Dec; 17(1):402. PubMed ID: 31796037
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of circulating tumor cells in patients with small cell lung cancer.
Naito T; Tanaka F; Ono A; Yoneda K; Takahashi T; Murakami H; Nakamura Y; Tsuya A; Kenmotsu H; Shukuya T; Kaira K; Koh Y; Endo M; Hasegawa S; Yamamoto N
J Thorac Oncol; 2012 Mar; 7(3):512-9. PubMed ID: 22258473
[TBL] [Abstract][Full Text] [Related]
16. The value of serum Bcl-2 levels in advanced lung cancer patients.
Tas F; Duranyildiz D; Oguz H; Camlica H; Oral EN; Yasasever V; Topuz E
Med Oncol; 2005; 22(2):139-43. PubMed ID: 15965276
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic value of serum procalcitonin concentrations in primary lung cancers.
Patout M; Salaün M; Brunel V; Bota S; Cauliez B; Thiberville L
Clin Biochem; 2014 Dec; 47(18):263-7. PubMed ID: 25218831
[TBL] [Abstract][Full Text] [Related]
18. Serum pro-gastrin-releasing peptide is a useful marker for treatment monitoring and survival in small-cell lung cancer.
Sunaga N; Tsuchiya S; Minato K; Watanabe S; Fueki N; Hoshino H; Makimoto T; Ishihara S; Saito R; Mori M
Oncology; 1999; 57(2):143-8. PubMed ID: 10461062
[TBL] [Abstract][Full Text] [Related]
19. Serum low-density lipoprotein and low-density lipoprotein expression level at diagnosis are favorable prognostic factors in patients with small-cell lung cancer (SCLC).
Zhou T; Zhan J; Fang W; Zhao Y; Yang Y; Hou X; Zhang Z; He X; Zhang Y; Huang Y; Zhang L
BMC Cancer; 2017 Apr; 17(1):269. PubMed ID: 28410578
[TBL] [Abstract][Full Text] [Related]
20. Application of Serum ELAVL4 (HuD) Antigen Assay for Small Cell Lung Cancer Diagnosis.
Wang F; Lu J; Li S; Huo X; Liu X; Du X; Li C; Wang J; Chen Z
Anticancer Res; 2017 Aug; 37(8):4515-4522. PubMed ID: 28739747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]